Why GPX?

The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions.*

Therapeutic, super-selective embolization is a high-growth procedure used for minimally invasive, targeted treatment of internal bleeds, tumors, aneurysms, vascular malformations, uterine fibroids, varicose veins, and other uses. Millions of embolization devices are used each year for these types of procedures across peripheral vascular, interventional oncology, and neurovascular applications.

Embolic devices today can be difficult to use and lack controllability and precision in delivery.  Particles and microspheres are useful embolics across a variety of applications, however they can be difficult to control, typically are not radiopaque, and do not allow the clinician to create a targeted plug.  Metallic coils can create a plug to occlude flow, but can be unpredictable during delivery and often require numerous, expensive deployments to achieve the desired occlusion. Liquid embolics have advantages for certain targeted procedures, but require special materials and delivery techniques, and use can result in accidental catheter entrapment in the body.


GPX Embolic Device*

GPX Embolic Device is currently in development and is designed for ease of use, versatility, and improved control during vascular embolization.


The GPX technology is a low viscosity, aqueous-based solution in a syringe that solidifies into a durable embolic material upon delivery, without polymerization or dimethyl-sulfoxide (DMSO) precipitation associated with other embolics.

GPX is packaged ready-to-use in a syringe, requires less than 1 minute of tableside preparation by the clinician, and may be delivered through standard catheters or microcatheters.    


Tumor Devascularization**

Baseline angiogram

Angiogram post-GPX delivery through microcatheter

DSA post-GPX delivery


Venous Applications**

Baseline angiogram

Angiogram post-GPX delivery through microcatheter

DSA post-GPX delivery


Interventional Oncology Use**

Baseline angiogram

DSA post-GPX delivery


Super-Selective Embolization**

Baseline angiogram

Angiogram post-GPX delivery through microcatheter

Angiogram post-GPX delivery selected sites


Coil Embolization with GPX**

Initial Angiogram

Platinum Coil Placement

Post Coil Angiogram
(minimal occlusion)

GPX Placed Proximal to Coil
(full occlusion)


Effective Distal Penetration**

GPX in Kidney - Demonstrating Distal Penetration

GPX in Kidney (magnified)


GPX Versatility**

Vascular Malformations

GPX in vascular malformation


GPX fills aneurysm

Portal Vein - Before GPX

Baseline angiogram

Portal Vein - Occluded with GPX

Post - GPX angiogram (full occlusion)


*Fluidx Medical Technology data on file

**Clinical case and in-vivo data on file

The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time. In New Zealand only, the GPX Embolic Device is an investigational device. For investigational use only in New Zealand.

© 2021 Fluidx Medical Technology, Inc.